195 related articles for article (PubMed ID: 37219874)
1. PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma.
Mondal I; Das O; Sun R; Gao J; Yu B; Diaz A; Behnan J; Dubey A; Meng Z; Eskandar E; Xu B; Lu RO; Ho WS
Cancer Res; 2023 Aug; 83(15):2527-2542. PubMed ID: 37219874
[TBL] [Abstract][Full Text] [Related]
2. PP2Ac/STRN4 negatively regulates STING-type I IFN signaling in tumor-associated macrophages.
Ho WS; Mondal I; Xu B; Das O; Sun R; Chiou P; Cai X; Tahmasebinia F; McFadden E; Wu CY; Wu Z; Matsui W; Lim M; Meng Z; Lu RO
J Clin Invest; 2023 Mar; 133(6):. PubMed ID: 36757811
[TBL] [Abstract][Full Text] [Related]
3. Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma.
Low JT; Brown MC; Reitman ZJ; Bernstock JD; Markert JM; Friedman GK; Waitkus MS; Bowie ML; Ashley DM
J Clin Invest; 2024 Jan; 134(2):. PubMed ID: 38226619
[TBL] [Abstract][Full Text] [Related]
4. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
[TBL] [Abstract][Full Text] [Related]
5. Ectopic expression of cGAS in
Waanders L; van der Donk LEH; Ates LS; Maaskant J; van Hamme JL; Eldering E; van Bruggen JAC; Rietveld JM; Bitter W; Geijtenbeek TBH; Kuijl CP
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072345
[TBL] [Abstract][Full Text] [Related]
6. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment.
Kho VM; Mekers VE; Span PN; Bussink J; Adema GJ
Cell Immunol; 2021 Apr; 362():104298. PubMed ID: 33592541
[TBL] [Abstract][Full Text] [Related]
7. Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists.
Pan X; Zhang W; Guo H; Wang L; Wu H; Ding L; Yang B
Biochem Pharmacol; 2023 Jul; 213():115596. PubMed ID: 37201875
[TBL] [Abstract][Full Text] [Related]
8. cGAS-STING pathway targeted therapies and their applications in the treatment of high-grade glioma.
Tripathi S; Najem H; Mahajan AS; Zhang P; Low JT; Stegh AH; Curran MA; Ashley DM; James CD; Heimberger AB
F1000Res; 2022; 11():1010. PubMed ID: 36324813
[TBL] [Abstract][Full Text] [Related]
9. Zebularine elevates STING expression and enhances cGAMP cancer immunotherapy in mice.
Lai J; Fu Y; Tian S; Huang S; Luo X; Lin L; Zhang X; Wang H; Lin Z; Zhao H; Lin S; Zhao J; Xu S; Li D; Cai S; Dong L; Qian J; Liang J; Li Q; Zhang Y; Fan J; Balderas R; Chen Q
Mol Ther; 2021 May; 29(5):1758-1771. PubMed ID: 33571681
[TBL] [Abstract][Full Text] [Related]
10. Manganese facilitated cGAS-STING-IFNI pathway activation induced by ionizing radiation in glioma cells.
He Y; Yang Y; Huang W; Yang S; Xue X; Zhu K; Tan H; Sun T; Yang W
Int J Radiat Biol; 2023; 99(12):1890-1907. PubMed ID: 37406172
[TBL] [Abstract][Full Text] [Related]
11. Cancer Immunotherapy Based on Cell Membrane-Coated Nanocomposites Augmenting cGAS/STING Activation by Efferocytosis Blockade.
Chen Z; Li Z; Huang H; Shen G; Ren Y; Mao X; Wang L; Li Z; Wang W; Li G; Zhao B; Guo W; Hu Y
Small; 2023 Oct; 19(43):e2302758. PubMed ID: 37381095
[TBL] [Abstract][Full Text] [Related]
12. cGAS/cGAMP/STING signal propagation in the tumor microenvironment: Key role for myeloid cells in antitumor immunity.
Mekers VE; Kho VM; Ansems M; Adema GJ
Radiother Oncol; 2022 Sep; 174():158-167. PubMed ID: 35870728
[TBL] [Abstract][Full Text] [Related]
13. STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models.
Berger G; Knelson EH; Jimenez-Macias JL; Nowicki MO; Han S; Panagioti E; Lizotte PH; Adu-Berchie K; Stafford A; Dimitrakakis N; Zhou L; Chiocca EA; Mooney DJ; Barbie DA; Lawler SE
Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2111003119. PubMed ID: 35787058
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of tumor intrinsic BANF1 activates antitumor immune responses via cGAS-STING and enhances the efficacy of PD-1 blockade.
Wang M; Huang Y; Chen M; Wang W; Wu F; Zhong T; Chen X; Wang F; Li Y; Yu J; Wu M; Chen D
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37620043
[TBL] [Abstract][Full Text] [Related]
15. Specific activation of cGAS-STING pathway by nanotherapeutics-mediated ferroptosis evoked endogenous signaling for boosting systemic tumor immunotherapy.
Liang JL; Jin XK; Zhang SM; Huang QX; Ji P; Deng XC; Cheng SX; Chen WH; Zhang XZ
Sci Bull (Beijing); 2023 Mar; 68(6):622-636. PubMed ID: 36914548
[TBL] [Abstract][Full Text] [Related]
16. Cancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity.
Schadt L; Sparano C; Schweiger NA; Silina K; Cecconi V; Lucchiari G; Yagita H; Guggisberg E; Saba S; Nascakova Z; Barchet W; van den Broek M
Cell Rep; 2019 Oct; 29(5):1236-1248.e7. PubMed ID: 31665636
[TBL] [Abstract][Full Text] [Related]
17. GAS-STING: a classical DNA recognition pathways to tumor therapy.
Wang X; Lin M; Zhu L; Ye Z
Front Immunol; 2023; 14():1200245. PubMed ID: 37920470
[TBL] [Abstract][Full Text] [Related]
18. Restriction of Human Cytomegalovirus Replication by ISG15, a Host Effector Regulated by cGAS-STING Double-Stranded-DNA Sensing.
Bianco C; Mohr I
J Virol; 2017 May; 91(9):. PubMed ID: 28202760
[TBL] [Abstract][Full Text] [Related]
19. NR1D1 Stimulates Antitumor Immune Responses in Breast Cancer by Activating cGAS-STING Signaling.
Ka NL; Park MK; Kim SS; Jeon Y; Hwang S; Kim SM; Lim GY; Lee H; Lee MO
Cancer Res; 2023 Sep; 83(18):3045-3058. PubMed ID: 37395684
[TBL] [Abstract][Full Text] [Related]
20. Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation.
Du SS; Chen GW; Yang P; Chen YX; Hu Y; Zhao QQ; Zhang Y; Liu R; Zheng DX; Zhou J; Fan J; Zeng ZC
Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1243-1255. PubMed ID: 34986380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
